In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- NYRA to Cap Belmont Attendance at 90,000
- MarketWatch: Jamie Hill on Sires, Pinhooking
- Powers, Billy Kelly Selected for Hall of Fame
- Keeneland Simulcast Operations to Red Mile
- Goo Goo Dolls to Perform Belmont Weekend
- 1995 Kentucky Derby Race Sequence
- Williamson Joins American Horse Council Staff
- Inglis Reports Productive Four-Day Auction
- Mr. Z Camp Still Undecided on Preakness
- Old English Rancho Owner Johnston Dies at 77